MFS
MCRB icon

MSI Financial Services’s Seres Therapeutics MCRB Stock Holding History

MSI Financial Services’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$3K Hold
14
– – ﹤0.01% 3361
2016
Q3 		$3K Hold
14
– – ﹤0.01% 3353
2016
Q2 		$8K Hold
14
– – ﹤0.01% 2890
2016
Q1 		$7K Buy
14
+8
+133% +$4.17K ﹤0.01% 2989
2015
Q4 		$4K Buy
+6
New +$3.94K ﹤0.01% 3195

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

MSI Financial Services's MCRB Position: Q4 2016 in Review

MSI Financial Services held its Seres Therapeutics (MCRB) position steady in Q4 2016 at 14 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #3361.

MSI Financial Services first reported a position in MCRB in Q4 2015 and has held it in 5 quarters since. The position peaked at $8K in Q2 2016. 89 funds tracked by Wall St. Rank hold MCRB as of Q4 2016.

  • MSI Financial Services held 14 shares of Seres Therapeutics worth $3K as of Q4 2016.
  • MSI Financial Services left its Seres Therapeutics share count unchanged in Q4 2016.
  • Seres Therapeutics made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #3361 holding.
  • MSI Financial Services first reported a position in Seres Therapeutics in Q4 2015 and has held it in 5 quarters since.
  • MSI Financial Services's Seres Therapeutics position peaked at $8K in Q2 2016.
  • 89 funds tracked by Wall St. Rank held Seres Therapeutics as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.